Showing results (1-10 of 579) with videos related to
Sort By:
Pageof 58
F1000Research|February 25, 2017
The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcomePeter Humaidan, Carlo Alviggi, Robert Fischer, et al.Frontiers in Endocrinology|October 2, 2019
Management Strategies for POSEIDON Groups 3 and 4Thor Haahr, Carlos Dosouto, Carlo Alviggi, et al.Frontiers in Endocrinology|July 30, 2019
Future Perspectives of POSEIDON Stratification for Clinical Practice and ResearchPeter Humaidan, Antonio La Marca, Carlo Alviggi, et al.Best Practice & Research. Clinical Obstetrics & Gynaecology|June 20, 2022
POSEIDON groups and their distinct reproductive outcomes: Effectiveness and cost-effectiveness insights from real-world data researchSandro C Esteves, Hakan Yarali, Lan N Vuong, et al.Frontiers in Endocrinology|September 4, 2018
Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The WhySandro C Esteves, Matheus Roque, Giuliano M Bedoschi, et al.Reproductive Biomedicine Online|May 18, 2023
Towards infertility care on equal terms: a prime time for male infertilitySandro C Esteves, Peter HumaidanHuman Reproduction (Oxford, England)|April 28, 2026
Sperm DNA fragmentation: how to test, when to test, and what to do with abnormal results-a pragmatic mini-review for clinical practiceSandro C Esteves, Peter HumaidanReproductive Biology and Endocrinology : RB&E|January 12, 2025
The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practiceSandro C Esteves, Peter HumaidanHuman Reproduction (Oxford, England)|March 21, 2026
From tablets to targeted therapy: the APHRODITE era in male infertilitySandro C Esteves, Peter HumaidanFertility and Sterility|April 15, 2018
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic reviewCarlo Alviggi, Alessandro Conforti, Sandro C Esteves, et al.Pageof 58